HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$2.66
Day range
$2.64 - $2.70
Year range
$1.56 - $4.27
Market cap
166.28M USD
Avg Volume
131.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 11.29M | 25.41% |
Net income | -12.37M | -35.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.60M | 42.48% |
Total assets | 27.66M | 37.72% |
Total liabilities | 109.80M | 54.20% |
Total equity | -82.15M | — |
Shares outstanding | 62.28M | — |
Price to book | -1.97 | — |
Return on assets | -105.43% | — |
Return on capital | -229.28% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -12.37M | -35.74% |
Cash from operations | -8.33M | 15.25% |
Cash from investing | — | — |
Cash from financing | 10.38M | 3.76% |
Net change in cash | 2.04M | 1,123.35% |
Free cash flow | -4.90M | 28.60% |
About
Founded
2000
Headquarters
Website
Employees
14